Inogen's overall fourth-quarter 2024 results continue to gain from higher business-to-business sales.

The strength in OPKO Health's transfer of intellectual property and other revenues boosts its overall fourth-quarter 2024 performance despite lower...

Clover Health's fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.

TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and Interventional segments.

Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract. Shares rise in pre-market.

Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.

VITL's fourth-quarter results reflect higher sales and earnings. Also, the adjusted EBITDA margin increases 130 basis points to 11.5% in the quarter.

BBWI's fourth-quarter results reflect lower y/y revenues and higher earnings. The operating margin increases 40 basis points to 24.3% in the quarter.

Hims & Hers' revenue channels witness strong growth on the back of solid product demand in the fourth quarter.

KDP's fourth-quarter 2024 results benefit from continued brand strength and improvements in volume/mix performance.